Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New discovery about Parkinson's at the Montreal Neurological Institute

02.08.2006
As a world-class medical centre, the Montreal Neurological Institute and Hospital (MNI) at McGill University is able to treat patients with Parkinson’s and make important discoveries about the disease all under the same roof.

Dr. Edward Fon, a neurologist and researcher at the MNI, studies Parkinson's disease (PD), a neurodegenerative disease that causes muscle stiffness and tremor and prevents people from controlling their movements in a normal manner. PD is estimated to affect about 100,000 Canadians.

By studying defects in the genes of patients with inherited forms of PD, Dr. Fon and his team have learned about the cellular mechanisms that are involved in the death of dopamine nerve cells, which is the main characteristic of the disease. In a recent study that was funded by the Michael J. Fox Foundation and the Canadian Institutes for Health Research and published in the prestigious journal Nature Cell Biology, Dr. Fon and his colleagues made a new discovery about parkin, a gene that is responsible for a common inherited form of PD. “We have found that parkin plays a novel role in a signaling pathway that controls nerve cell survival,” explains Dr. Fon. “This new function is completely different from the role parkin was traditionally thought to play. Moreover, this pathway—called the Akt signaling pathway—has recently been linked to other neurodegenerative diseases in addition to PD. This new-found interaction between Akt and parkin suggests that PD and other neurodegenerative disorders may share certain key mechanisms of cell death, which now gives us a whole new set of potential treatment targets.”

Along with his research, Dr. Fon is also a clinician at the Movement Disorder Clinic of the MNI, which provides the best in health care and services to people with PD across the country. In fact, it was recently awarded a Clinical Assistance Grant from Parkinson Society Canada for its excellence in clinical service and received an outstanding score that put it amongst the top tier of eligible candidates nationwide. The clinic takes a multidisciplinary approach to patient care, and clinic director Dr. Anne-Louise Lafontaine emphasizes that “newly diagnosed patients have the opportunity of being evaluated by a neurologist, a clinical nurse specialist and other health care professionals on the same clinic day. Follow-up appointments with the team members are arranged as needed to follow progress and offer advice on an ongoing basis.” The clinic therefore strives to offer continuity of care and facilitates this through “one stop shopping.”

Facts about Parkinson’s

Parkinson's disease is a chronic, progressive disorder of the central nervous system that belongs to a group of conditions called motor system disorders.

Symptoms of Parkinson's, which often appear gradually yet with increasing severity, may include tremors or trembling; difficulty maintaining balance and gait; rigidity or stiffness of the limbs and trunk; and general slowness of movement (also called bradykinesia).

It is currently impossible to predict who will get Parkinson's disease or to prevent it from occurring. In general, both men and women are affected equally and symptoms first appear, on average, when a patient is older than 50.

(Source: Michael J. Fox Foundation)

For more information about Parkinson’s, visit the web site of Parkinson Society Canada at http://www.parkinson.ca/ or the Michael J. Fox Foundation at http://www.michaeljfox.org/parkinsons/index.php.

The Montreal Neurological Institute (www.mni.mcgill.ca) is a McGill University (www.mcgill.ca) research and teaching institute, dedicated to the study of the nervous system and neurological diseases. Founded in 1934 by the renowned Dr. Wilder Penfield, the MNI is one of the world’s largest institutes of its kind. MNI researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. The MNI, with its clinical partner, the Montreal Neurological Hospital (MNH), part of the McGill University Health Centre (www.muhc.ca), continues to integrate research, patient care and training, and is recognized as one of the premier neuroscience centres in the world. Already well known for its McConnell Brain Imaging Centre, the MNI will expand its brain imaging research in the next several years through a $28 million award from the Canada Foundation for Innovation, made in partnership with the government of Quebec. There will also be further development of MNI initiatives in multiple sclerosis, optical imaging and nano-neuroscience.

Amy Butcher | EurekAlert!
Further information:
http://www.mcgill.ca

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>